Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Atrys Health SA ( (ES:ATRY) ) has provided an update.
Atrys Health, S.A. has announced changes to its board of directors following the recent Ordinary General Shareholders’ Meeting. Key changes include the election of Ms. María Antonia Isach Gabaldón as an executive director and the re-election of Mr. Santiago de Torres Sanahuja and Ms. Isabel Lozano Fernández as directors. Additionally, Mr. Jaime del Barrio Seoane has resigned due to new professional commitments. These changes are likely to impact the company’s strategic direction and governance, potentially influencing its market positioning and stakeholder relations.
The most recent analyst rating on (ES:ATRY) stock is a Buy with a EUR5.00 price target. To see the full list of analyst forecasts on Atrys Health SA stock, see the ES:ATRY Stock Forecast page.
More about Atrys Health SA
Atrys Health, S.A. operates in the healthcare industry, focusing on providing innovative medical services and solutions. The company is known for its commitment to advancing healthcare through technology and specialized services, catering to a diverse market that includes both private and public healthcare sectors.
YTD Price Performance: -18.69%
Average Trading Volume: 75,764
Technical Sentiment Signal: Strong Sell
Current Market Cap: €208.2M
Find detailed analytics on ATRY stock on TipRanks’ Stock Analysis page.